Cabot (NYSE:CBT) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Cabot (NYSE:CBTGet Free Report) announced its quarterly earnings results on Monday. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $1.81 by ($0.01), Briefing.com reports. The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1.01 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. The firm’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.65 earnings per share. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.

Cabot Price Performance

Shares of NYSE:CBT traded down $1.87 during trading on Tuesday, reaching $108.22. The stock had a trading volume of 346,299 shares, compared to its average volume of 336,112. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. The business has a fifty day moving average price of $108.30 and a 200-day moving average price of $101.01. The stock has a market cap of $5.93 billion, a PE ratio of 12.87, a PEG ratio of 0.91 and a beta of 1.20. Cabot has a 1-year low of $66.02 and a 1-year high of $117.14.

Insider Transactions at Cabot

In other news, CFO Erica Mclaughlin sold 23,274 shares of Cabot stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total value of $2,322,512.46. Following the sale, the chief financial officer now directly owns 59,814 shares of the company’s stock, valued at $5,968,839.06. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other Cabot news, CFO Erica Mclaughlin sold 23,274 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the transaction, the chief financial officer now owns 59,814 shares of the company’s stock, valued at approximately $5,968,839.06. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Sean D. Keohane sold 25,617 shares of the business’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total value of $2,601,406.35. Following the transaction, the chief executive officer now directly owns 331,174 shares in the company, valued at $33,630,719.70. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 71,939 shares of company stock valued at $7,308,812 over the last ninety days. Insiders own 3.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. JPMorgan Chase & Co. lifted their price target on Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. Mizuho raised their price objective on Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a report on Tuesday. Finally, UBS Group dropped their price objective on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Cabot has a consensus rating of “Hold” and a consensus price target of $105.00.

Read Our Latest Stock Report on Cabot

Cabot Company Profile

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Stories

Earnings History for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.